131 related articles for article (PubMed ID: 3353875)
41. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus.
Bogie AL; Towne D; Luckett PM; Abramo TJ; Wiebe RA
Pediatr Emerg Care; 2007 Jun; 23(6):355-61. PubMed ID: 17572517
[TBL] [Abstract][Full Text] [Related]
42. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
Nicolson CH; Stirling RG; Borg BM; Button BM; Wilson JW; Holland AE
Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069
[TBL] [Abstract][Full Text] [Related]
43. High-dose inhaled terbutaline in the management of chronic severe asthma: comparison of wet nebulisation and tube-spacer delivery.
Prior JG; Nowell RV; Cochrane GM
Thorax; 1982 Apr; 37(4):300-3. PubMed ID: 7112461
[TBL] [Abstract][Full Text] [Related]
44. Influence of breathing pattern on lung deposition and bronchodilator response to nebulised salbutamol in patients with stable asthma.
Zainudin BM; Tolfree SE; Short M; Spiro SG
Thorax; 1988 Dec; 43(12):987-91. PubMed ID: 3238642
[TBL] [Abstract][Full Text] [Related]
45. Enhanced clearance of secretions from the human lung after the administration of hypertonic saline aerosol.
Pavia D; Thomson ML; Clarke SW
Am Rev Respir Dis; 1978 Feb; 117(2):199-203. PubMed ID: 637404
[TBL] [Abstract][Full Text] [Related]
46. Is cough as effective as chest physiotherapy in the removal of excessive tracheobronchial secretions?
Bateman JR; Newman SP; Daunt KM; Sheahan NF; Pavia D; Clarke SW
Thorax; 1981 Sep; 36(9):683-7. PubMed ID: 7031979
[TBL] [Abstract][Full Text] [Related]
47. Comparison of three techniques of inhalation on the airway response to terbutaline.
Cushley MJ; Lewis RA; Tattersfield AE
Thorax; 1983 Dec; 38(12):908-13. PubMed ID: 6665750
[TBL] [Abstract][Full Text] [Related]
48. Do oral and inhaled terbutaline have different effects on the lung?
Shaw RJ; Waller JF; Hetzel MR; Clark TJ
Br J Dis Chest; 1982 Apr; 76(2):171-6. PubMed ID: 7046781
[TBL] [Abstract][Full Text] [Related]
49. Acute hypotension associated with terbutaline nebuliser therapy in a traumatic tetraplegic patient during the spinal shock phase. Case report.
Soni BM; Vaidyanathan S; Fraser MH; Watt JH; Krishnan KR
Paraplegia; 1995 May; 33(5):300-1. PubMed ID: 7630660
[TBL] [Abstract][Full Text] [Related]
50. The efficacy of terbutaline and fenoterol aerosols on adult exercise-induced asthma [proceedings].
Tammivaara R
Scand J Respir Dis Suppl; 1979; 103():212-3. PubMed ID: 373092
[No Abstract] [Full Text] [Related]
51. A dose-response study of inhaled terbutaline administered via Nebuhaler or nebuliser to asthmatic children.
Blackhall MI; O'Donnell SR
Eur J Respir Dis; 1987 Aug; 71(2):96-101. PubMed ID: 3622669
[TBL] [Abstract][Full Text] [Related]
52. Airway clearance techniques for bronchiectasis.
Lee AL; Burge A; Holland AE
Cochrane Database Syst Rev; 2013 May; (5):CD008351. PubMed ID: 23728674
[TBL] [Abstract][Full Text] [Related]
53. Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis: Is there evidence?
Snijders D; Fernandez Dominguez B; Calgaro S; Bertozzi I; Escribano Montaner A; Perilongo G; Barbato A
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):150-9. PubMed ID: 26078380
[TBL] [Abstract][Full Text] [Related]
54. The efficacy of drug delivery by a pear-shaped spacer and metered dose inhaler.
Morris J; Milledge JS; Moszoro H; Higgins A
Br J Dis Chest; 1984 Oct; 78(4):383-7. PubMed ID: 6487528
[TBL] [Abstract][Full Text] [Related]
55. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient.
Bott J; Blumenthal S; Buxton M; Ellum S; Falconer C; Garrod R; Harvey A; Hughes T; Lincoln M; Mikelsons C; Potter C; Pryor J; Rimington L; Sinfield F; Thompson C; Vaughn P; White J;
Thorax; 2009 May; 64 Suppl 1():i1-51. PubMed ID: 19406863
[No Abstract] [Full Text] [Related]
56. The therapeutic value of oral long-term treatment with terbutaline (Bricanyl) in asthma. A follow-up study of its efficacy and side effects.
Formgren H
Scand J Respir Dis; 1975; 56(6):321-8. PubMed ID: 1221498
[TBL] [Abstract][Full Text] [Related]
57. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
58. Regional lung clearance during cough and forced expiration technique (FET): effects of flow and viscoelasticity.
Hasani A; Pavia D; Agnew JE; Clarke SW
Thorax; 1994 Jun; 49(6):557-61. PubMed ID: 8016793
[TBL] [Abstract][Full Text] [Related]
59. Addition of intravenous beta(2)-agonists to inhaled beta(2)-agonists for acute asthma.
Travers AH; Milan SJ; Jones AP; Camargo CA; Rowe BH
Cochrane Database Syst Rev; 2012 Dec; 12():CD010179. PubMed ID: 23235685
[TBL] [Abstract][Full Text] [Related]
60. Nonpharmacologic airway clearance therapies: ACCP evidence-based clinical practice guidelines.
McCool FD; Rosen MJ
Chest; 2006 Jan; 129(1 Suppl):250S-259S. PubMed ID: 16428718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
